MOLECULAR CHARACTERIZATION OF THE RHODOPSIN GENE

视紫红质基因的分子特征

基本信息

项目摘要

Rhodopsin, the major integral membrane protein of the rod outer segment of photoreceptor cells, initiates the complex cascade of events associated with the process of vision, by the absorption of a photon of light. The relationship of both the structural characteristics of the rhodopsin gene and the molecular mechanisms regulating its expression, to the survival of photoreceptor cells is an important neurobiological problem about which relatively little is known. In the mouse retina, the homozygous presence of the rds (retinal degeneration slow) mutation is associate with a) the absence of 97% of the normal amounts of rhodopsin; b) the failure of rod outer segments to develop; and c) the genetically programmed premature cell death of rod photoreceptor cells. The heterozygote (rds/+) has only half the level of rhodopsin as normal and has morphologically shorter and less well organized rod outer segments. Collectively, these data indicate that the rds mutation is either a "cis acting" regulatory gene adjacent to the rhodopsin gene or it is actually within the structural gene for rhodopsin. Our overall objective is to define and characterize the rhodopsin gene and its expression during development in normal and rds mice. We constructed a mouse retinal cDNA expression library, cloned and partially sequenced mouse rhodopsin cDNA and have obtained monoclonal and monospecific antibodies against rhodopsin. We are now proposing to: a) characterize both qualitatively and quantitatively by Northern and Western alalysis, the rhodopsin gene products (mRNA and opsin) during development of normal, heterozygote and rds mice; b) clone and sequence the rhodopsin gene from genomic libraries of normal and rds mice; and c) determine the chromosomal assignment and the exact locus of the mouse rhodopsin gene using Southern Analysis of restriction fragments from a mouse-Chinese hamster somatic cell hybrid chromosome panel and from recombinant inbred lines of mice. The expression of other retina specific genes will also be monitored in order to characterize the biochemical phenotype of the rds mutation during the development and degeneration of photoreceptor cells. The results obtained from this study will have importance for the study of hereditary blindness (e.g. retinitis pigmentosa) and will provide a mammalian model for studying the exact molecular events associated with genetically controlled degeneration of a unique population of neurons, in the central nervous system.
视紫红质(Rhodopsin)是水稻杆外段的主要整体膜蛋白

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES Francis MCGINNIS其他文献

JAMES Francis MCGINNIS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES Francis MCGINNIS', 18)}}的其他基金

Prolonged Inhibition of Pathologic Neovascularization by Catalytic Antioxidants
催化抗氧化剂对病理性新血管形成的长期抑制
  • 批准号:
    8607958
  • 财政年份:
    2012
  • 资助金额:
    $ 16.87万
  • 项目类别:
Prolonged Inhibition of Pathologic Neovascularization by Catalytic Antioxidants
催化抗氧化剂对病理性新血管形成的长期抑制
  • 批准号:
    8222309
  • 财政年份:
    2012
  • 资助金额:
    $ 16.87万
  • 项目类别:
Prolonged Inhibition of Pathologic Neovascularization by Catalytic Antioxidants
催化抗氧化剂对病理性新血管形成的长期抑制
  • 批准号:
    8415878
  • 财政年份:
    2012
  • 资助金额:
    $ 16.87万
  • 项目类别:
Prolonged Inhibition of Pathologic Neovascularization by Catalytic Antioxidants
催化抗氧化剂对病理性新血管形成的长期抑制
  • 批准号:
    8798665
  • 财政年份:
    2012
  • 资助金额:
    $ 16.87万
  • 项目类别:
Cellular Imaging and Morphometric Analysis Core
细胞成像和形态测量分析核心
  • 批准号:
    10011811
  • 财政年份:
    2011
  • 资助金额:
    $ 16.87万
  • 项目类别:
COBRE:OUHSC: IMAGE ACQUISITION & PRODUCTION CORE
COBRE:OUHSC:图像采集
  • 批准号:
    8360403
  • 财政年份:
    2011
  • 资助金额:
    $ 16.87万
  • 项目类别:
COBRE:OUHSC: IMAGE ACQUISITION & PRODUCTION CORE
COBRE:OUHSC:图像采集
  • 批准号:
    8168347
  • 财政年份:
    2010
  • 资助金额:
    $ 16.87万
  • 项目类别:
Prevention of Inherited Retinal Diseases by Therapeutic Rare Earth Nanoparticles
通过治疗性稀土纳米颗粒预防遗传性视网膜疾病
  • 批准号:
    7583201
  • 财政年份:
    2009
  • 资助金额:
    $ 16.87万
  • 项目类别:
COBRE:OUHSC: IMAGE ACQUISITION & PRODUCTION CORE
COBRE:OUHSC:图像采集
  • 批准号:
    7959974
  • 财政年份:
    2009
  • 资助金额:
    $ 16.87万
  • 项目类别:
Prevention of Inherited Retinal Diseases by Therapeutic Rare Earth Nanoparticles
通过治疗性稀土纳米颗粒预防遗传性视网膜疾病
  • 批准号:
    7895588
  • 财政年份:
    2009
  • 资助金额:
    $ 16.87万
  • 项目类别:

相似海外基金

CAREER: Elucidating spatial and epigenetic regulation of gene expression during human development using photopatterning and single-cell multiomics
职业:利用光模式和单细胞多组学阐明人类发育过程中基因表达的空间和表观遗传调控
  • 批准号:
    2339849
  • 财政年份:
    2024
  • 资助金额:
    $ 16.87万
  • 项目类别:
    Continuing Grant
CAREER: Scalable algorithms for regularized and non-linear genetic models of gene expression
职业:基因表达的正则化和非线性遗传模型的可扩展算法
  • 批准号:
    2336469
  • 财政年份:
    2024
  • 资助金额:
    $ 16.87万
  • 项目类别:
    Continuing Grant
CAREER: Epigenetic Regulation of Gene Expression in Engineered Prokaryotes
职业:工程原核生物基因表达的表观遗传调控
  • 批准号:
    2338573
  • 财政年份:
    2024
  • 资助金额:
    $ 16.87万
  • 项目类别:
    Continuing Grant
MFB: RNA modifications of frameshifting stimulators: cellular platforms to engineer gene expression by computational mutation predictions and functional experiments
MFB:移码刺激器的RNA修饰:通过计算突变预测和功能实验来设计基因表达的细胞平台
  • 批准号:
    2330628
  • 财政年份:
    2024
  • 资助金额:
    $ 16.87万
  • 项目类别:
    Standard Grant
22-BBSRC/NSF-BIO Building synthetic regulatory units to understand the complexity of mammalian gene expression
22-BBSRC/NSF-BIO 构建合成调控单元以了解哺乳动物基因表达的复杂性
  • 批准号:
    BB/Y008898/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.87万
  • 项目类别:
    Research Grant
How does the chromatin remodeller CHD4 regulate gene expression?
染色质重塑因子 CHD4 如何调节基因表达?
  • 批准号:
    DP240102119
  • 财政年份:
    2024
  • 资助金额:
    $ 16.87万
  • 项目类别:
    Discovery Projects
Application for 2024 CIHR NIF (ECR): Investigating the role of SARS-CoV-2 and MERS-CoV transcription regulatory sequence (TRS) in viral gene expression and virulence
2024 CIHR NIF (ECR) 申请:研究 SARS-CoV-2 和 MERS-CoV 转录调控序列 (TRS) 在病毒基因表达和毒力中的作用
  • 批准号:
    491942
  • 财政年份:
    2023
  • 资助金额:
    $ 16.87万
  • 项目类别:
Regulation of gene expression by the La and La-related proteins
La 和 La 相关蛋白对基因表达的调节
  • 批准号:
    489704
  • 财政年份:
    2023
  • 资助金额:
    $ 16.87万
  • 项目类别:
    Operating Grants
Investigating the role of SARS-CoV-2 and MERS-CoV transcription regulatory sequence (TRS) in viral gene expression and virulence
研究 SARS-CoV-2 和 MERS-CoV 转录调控序列 (TRS) 在病毒基因表达和毒力中的作用
  • 批准号:
    494272
  • 财政年份:
    2023
  • 资助金额:
    $ 16.87万
  • 项目类别:
    Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
  • 批准号:
    493135
  • 财政年份:
    2023
  • 资助金额:
    $ 16.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了